Advance Your Discovery

Antibody Solutions: Delivering custom antibodies that advance better diagnostics and therapeutics. 

Science
Smart science that accelerates your research
Process
A proven process that you can trust
Sincerity
A certain sincerity that embraces your needs

Relentlessly eliminating your frustrations

When we first meet with a client, we often start right here: What's standing in the way of your success? And no matter their answer, we stand at the ready to help — with deep antibody expertise, diverse technology platforms and an overall customer experience model designed to make every new success seem more natural than the last.

Not just any antibody will do—I need it to do something specific

We’ll collaborate with you to develop the right antibody with the affinity, specificity and functionality you need. Keep reading

My antibody developer doesn’t understand my downstream goals

With expertise in key disciplines and an understanding of the requirements of different antibody applications, we have the science to put you on the right path. Keep reading

I’m not sure which antibody discovery strategies makes the most sense for us

When you collaborate with our team, you’re capitalizing on the custom antibody discovery expertise we’ve honed through 20+ years of experience serving more than 500 research organizations. Keep reading

I’m worried I'm not going to meet my objectives or deadlines

When it fits your project’s unique needs, we can pursue multiple discrete discovery paths simultaneously, keeping your program on-point and on-time. Keep reading

I’m tired of always being out of the loop on where things are—and where they’re going

Our proprietary process, auto checkpoint updates and project management excellence mean you’re never in the dark about the status of our work for you. Keep reading

My science should be my own, but my CRO or platform company wants future royalties

We believe you should have exclusive ownership rights to your research, so we adhere to a pay-as-you-go, fee-for-service model that keeps licensing where it rightly belongs—in your hands. Keep reading

Let’s talk about your science and goals

500+

biopharmaceutical companies served

96%

of clients return with new assignments

24+

years of helping clients succeed

9 of 10

top pharmas worldwide trust us

Insights

Post Show Analysis CAR-TCR Summit

After a couple weeks of tackling the tsunami of emails, meetings and project updates that greeted me after my two-week “conference marathon” in Boston last month, here is a summary of Discovery on Target 2019. And, like the CAR-TCR Summit the week before it, this year’s DOT (#17 in the series) offered a wide range of useful and interesting updates on the latest in antibody research.

Continue reading our full CAR-TCR post show review

 

Insights

Post Show Analysis Discovery On Target

You know, it’s true -- there’s no place like home (especially Antibody Solutions’ new home in Santa Clara, California). At the same time, though, I probably would have stayed another week in Boston had there been a third conference that was as chock full of engaging presentations, intriguing research and useful data (plus some very stimulating hallway conversations) as the two back-to-back conferences I attended earlier this month: CAR-TCR Summit 2019 and Discovery on Target 2019.

Continue reading our complete post show review of DOT 2019

Events

AET 2019


What could be better than San Diego in December?

This year's Antibody Engineering Conferences promises to be one of the best ever, and Antibody Solutions will be onsite through the week. Please drop by BOOTH 402, and let's start the conversation. And be sure to visit our poster presentations during the conference. We'll be sharing some very compelling research on generating neutralizing clones against soluble therapeutic proteins using  ATX-GX mice and how 3-D molecular modeling can accelerate and lower the cost of antibody discovery.

Schedule a meeting with our team

Our “Y” always begins with You

Let’s get the conversation started for your next custom antibody discovery project.